Clinical Trials
3 trialsNCT04865679 2026-06-03
REPOSE-XLâ„
Axogen Corporation
Phase NA Active not recruiting
NCT04063215 2026-01-15
A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy for the Treatment of Traumatic Brain Injury and Hypoxic-Ischemic Encephalopathy
Hope Biosciences Research Foundation
Phase 1/2 Completed
NCT05951777 2025-09-29
Autologous Adipose-Derived Mesenchymal Stem Cells for Chronic Traumatic Brain Injury
Hope Biosciences Research Foundation
Phase 2 Recruiting